key: cord-0989214-bboi6l69 authors: Zhou, Q.; Zhu, D.; Yan, H.; Quan, J.; Kuang, Z.; Zhang, W.; Huang, L.; Lei, T.; Liu, J.; Xiao, B.; Luo, A.; Sun, Z.; Li, L. title: A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice date: 2020-05-09 journal: nan DOI: 10.1101/2020.05.05.20092551 sha: bbbce6655150a87dd56cab98335930698f37a1ed doc_id: 989214 cord_uid: bboi6l69 Objective: To investigate the performance of serological test and dynamics of serum antibody with the progress of SARS-CoV-2 infections. Methods: A total of 419 patients were enrolled including 19 confirmed cases and 400 patients from fever clinics. Their serial serum samples collected during the hospitalization were menstruated for IgM and IgG against SARS-CoV-2 using gold immunochromatographic assay and chemiluminescence immunoassay. We investigated whether thermal inactivation could affect the results of antibody detection. The dynamics of antibodies with the disease progress and false positive factors for antibody testing were also analyzed. Results: The positive rate of IgG detection was 91.67% and 83.33% using two CLIA, respectively. However, the IgM positive rate was dramatically declined might due to the lack of blood samples at early stages of the disease. The chemiluminescence immunoassay had a favorable but narrow linear range. Our work showed increased IgG values in serums from virus-negative patients and four negative samples were IgG weak-positive after thermal incubation. Our data showed the specificity of viral N+S proteins was higher than single antigen. Unlike generally thought that IgM appeared earlier than IgG, there is no certain chronological order of IgM and IgG seroconversion in COVID-19 patients. It was difficult to detect antibodies in asymptomatic patients suggesting that their low viral loads were not enough to cause immune response. Analysis of common interferent in three IgG false-positive patients, such as rheumatoid factor, proved that false positives were not caused by these interfering substances and antigenic cross-reaction. Conclusions: Viral serological test is an effective means for SARS-CoV-2 infect detection using both chemiluminescence immunoassay and gold immunochromatographic assay. Chemiluminescence immunoassay against multi-antigens has obvious advantages but still need improve in reducing false positives. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.05.20092551 doi: medRxiv preprint u m i n e s c e n c e i m m u n o a s s a y a n d c o l l o i d a l g o l d i m m u n o c h r o m a t o g r a p h y t e s t T o q u a n t i t a t i v e l y d e t e c t a n . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. . a n d 4 6 3 p h a r y n g e a l s w a b s p e c i m e n s w e r e c o l l e c t e d . 2 . P e r f o r m a n c e o f C L I A f o r v i r a l a n t i b o d y d e t e c t i o n T o v a l i d a t e t h e p e r f o r m a n c e o f C L I A ( Y a h u i l o n g ) , a s e r i e s o f d i l u t i o n e x p e r i m e n t s w e r e p e r f o r m e d u s i n g s e r u m s a m p l e s f r o m 3 c o n f i r m e d C O V I D -1 9 p a t i e n t s w . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.05.20092551 doi: medRxiv preprint T o i n v e s t i g a t e t h e d y n a m i c s o f a n t i b o d y l e v e l s w i t h d i s e a s e p r o g r e s s i o n , w e c o n d u c t e d l o n g -t e r m a n t i b o d y l e v e l m o n i t o r i n g o n f i v e r e p r e s e n t a t i v e c o n f i r m e d c a s e s i n c l u d i n g o n e a s y m p t o m a t i c p a t i e n t . T h e f i r s t p o s i t i v e t i m e p o i n t o f A b t e s t s a p p e a r e d l a t e r t h a n t h a t o f R N A i n 4 o f 5 p a t i e n t s a s e x p e c t e d , e x c e p t f o r c a s e 8 . A b w a s d e t e c t a b l e a t t h e s a m e d a y w i . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020 May 9, . . https://doi.org/10.1101 May 9, /2020 doi: medRxiv preprint f a l s e p o s i t i v e s w e r e n o t c a u s e d b y t h e s e i n t e r f e r i n g s u b s t a n c e s . T h e r e s u l t s s u g g e s t e d t h a t f u r t h e r o p t i m i z a t i o n w a s n e e d e d t o i m p r o v e t h e d e t e c t i o n s p e c i f i c i t y . T h e p r e s e n t s t u d y h a s s o m e n o t a b l e l i m i t a t i o n s . F i r s t , o n l y 1 9 l a b o r a t o r y c o n f i r m e d C O V I D -1 9 p a t i e n t s w e r e i n c l u d e d . I t c a n ' t t e l l w h e t h e r c e r t a i n c o n c l u s i o n s w e r e e x c e p t i o n a l o . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. 1 3 . P a n Y , L o n g L , Z h a n g D , e t a l . P o t e n t i a l f a l s e -n e g a t i v e n u c l e i c a c i d t e s t i n g r e s u l t s f o r S e v e r e A c u t e R e s p i r a t o r y S y n d r o m e C o r o n a v i r u s 2 f r o m t h e r m a l i n a c t i v a t i o n o f s a m p l e s w i t h l o w v i r a l l o a d s . C l i n i c a l C h e m i s t r y 2 0 2 0 . 1 4 . Z h a n g W , D u R , L i B , e t a l . M o l e c u l a r a n d s e r o l o g i c a l i n v e s t i g a t i o n o f 2 0 1 9 -n C o V i n f e c t e d p a t i e n t . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 9, 2020. F i g u r e L e g e n d s F i g u r e 1 . I g G a n t i b o d y a s s a y l i n e a r i t y r e s u l t s u s i n g n e g a t i v e -s e r u m ( A ) a n d s a l i n e ( B ) d i l u e n t . S i x v i r u s -p o s i t i v e s e r u m s a m p l e s w e r e s e r i a l l y d i l u t e d b y a f a c t o r o f 2 t o 3 2 t i m e s . ( A ) T h e c o r r e l a t i o . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 9, 2020. . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 9, 2020. Lymphocytes (%; normal range 20%-40%)